Alkem Laboratories has denied allegations by the CDSCO that certain batches of its products, Pan-D and Clavam 625, failed to meet quality standards. The company asserted that the samples in question were fake after comparing them with actual batches. Alkem’s stock price saw a slight decline before closing marginally lower.
Related Posts
Michelle Bowman’s dissent is first from Fed Governor since 2005
Federal Reserve Governor Michelle Bowman dissented on an interest-rate decision for the first time since 2005, opposing a 50 basis point cut in favor of […]
Indian Railways’ 1st hydrogen train on tracks soon? India to become 5th country to operate hydrogen-powered trains
Indian Railways is set to launch its first hydrogen train, with trial runs expected in December 2024. The project includes 35 trains and significant investments […]